We're currently onboarding companies. Sign up to see when investments go live.
Successfully Funded on June 26, 2018
Processa Pharmaceuticals

Developing Products to Improve the Survival/Quality of Life for Patients with an Unmet Medical Need.

Amount Raised

$3,183,521

Investors

44

Days Left

Funded

Regulation D Offering

processapharmaceuticals.com
Hanover, MD
Following for updates
    Reg D Offering Summary
    Investors in Regulation D offerings must be accredited and are not subject to SEC investment limits.
    Amount Raised
    $3,183,520.97
    Investors
    44
    Security Type
    Common Stock and Warrants
    Shares Offered
    3,524,229
    Offering Min
    $2,500,000
    Offering Max
    $8,000,000
    Pre-Money Valuation
    $80,000,000
    Max Equity Offered
    9.09%
    Price Per Share
    $2.27
    Amendment to Term Sheet and PPM
    View
    Private Placement Memorandum PPM
    View
    Subscription Agreement
    View
    Securities Purchase Agreement
    View
    Common Stock Purchase Warrant
    View
    Investor Deck
    View